norelgestromin and ethinyl estradiol

FDA Drug Profile — Gwyn Lo, XULANE, norelgestromin and ethinyl estradiol

norelgestromin and ethinyl estradiol is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including Gwyn Lo, XULANE, norelgestromin and ethinyl estradiol. Available dosage form: patch.

Drug details

Generic Name
norelgestromin and ethinyl estradiol
Brand Names
Gwyn Lo, XULANE, norelgestromin and ethinyl estradiol
Application Number
NDA219990
Sponsor
Viatris Specialty LLC
NDC Codes
6
Dosage Forms
PATCH
Routes
TRANSDERMAL
Active Ingredients
NORELGESTROMIN, ETHINYL ESTRADIOL

Indications and Usage

1 INDICATIONS AND USAGE Norelgestromin and ethinyl estradiol transdermal system is indicated for the prevention of pregnancy in women with a body mass index (BMI) < 30 kg/m 2 for whom a combined hormonal contraceptive is appropriate. Limitations of Use: Norelgestromin and ethinyl estradiol transdermal system may be less effective in preventing pregnancy in women who weigh 198 lbs (90 kg) or more. Norelgestromin and ethinyl estradiol transdermal system is contraindicated for use in women with BMI ≥ 30 kg/m2 [ see Contraindications ( 4 ), Warnings and Precautions ( 5.1 ) and Clinical Studies ( 14 ) ]. Norelgestromin and ethinyl estradiol transdermal system is an estrogen/progestin combination hormonal contraceptive (CHC), indicated for the prevention of pregnancy in women with a BMI < 30 kg/m 2 for whom combined hormonal contraceptive is appropriate. ( 1 ) Limitations of Use: Norelgestromin and ethinyl estradiol transdermal system may be less effective in preventing pregnancy in women at or above 198 lbs (90 kg). ( 1 , 4 , 14 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.